EP05.02-002 Who Benefits More of Durvalumab after Chemoradiotherapy (CRT) in Real-World Patients with Locally Advanced Non-Small-Cell Lung Cancer (NSCLC)?

  1. Tavara, B.
  2. Garrido, M.L.
  3. Rodríguez, Z.
  4. Rojas, M.
  5. López, L.
  6. Medina, S.
  7. Ponte, C.
  8. Lopez, A.
  9. Sanchez, E.
  10. Pedraza, M.
  11. Viñals, P.
  12. López, M.
  13. Alonso, D.
  14. Rodríguez, A.
  15. Davila, E.
  16. Castañon, C.
  17. De Sande, L.M.
  18. Nieto, B.
  19. Vallejo Pascual, M.E. 1
  20. Rodríguez, J.d.l.R.
  21. Garcia Palomo, A.
  22. Diz Taín, P.
  1. 1 Universidad de León
    info

    Universidad de León

    León, España

    ROR https://ror.org/02tzt0b78

Aldizkaria:
Journal of Thoracic Oncology

ISSN: 1556-0864

Argitalpen urtea: 2022

Alea: 17

Zenbakia: 9

Orrialdeak: S283

Mota: Artikulua

DOI: 10.1016/J.JTHO.2022.07.484 GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Journal of Thoracic Oncology